<html>
<head>PUBMED IDs for MIRN21</head>
<body bgcolor='#C5F0F2'><h1>MIRN21</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17311248/'>Molecular characterization of the human common fragile site FRA1H.</a> February 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17311212/'>[Update on the molecular biology of gliomas: towards a pathomolecular classification of gliomas].</a> February 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17954271/'>Transcriptional profiling of genes at the human common fragile site FRA1H in tumor-derived cell lines.</a> October 24  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18253030/'>U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.</a> February 7  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18492109/'>Identification of erythropoietin-induced microRNAs in haematopoietic cells during erythroid differentiation.</a> May 22  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18537969/'>MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.</a> June 10  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19614619/'>miR-21 as a key regulator of oncogenic processes.</a> September 25  2009<br></body></html>
